A review of the last decade: pancreatic cancer and type 2 diabetes

被引：1

作者：

Wu, Jiaqi ^{[1
,2
]}

Tang, Liang ^{[3
]}

Zheng, Feng ^{[4
]}

Chen, Xun ^{[5
,6
]}

Li, Lei ^{[7
]}

机构：

[1] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China

[2] Southern Med Univ, Sch Nursing, Guangzhou, Peoples R China

[3] Zhuzhou Cent Hosp, Dept Gen Med, Zhuzhou, Peoples R China

[4] Univ Otago, Dept Anat, Dunedin, New Zealand

[5] Zhuzhou Cent Hosp, Dept Trauma Ctr, 116 Changjiang Rd, Zhuzhou 412000, Peoples R China

[6] Zhuzhou Cent Hosp, Dept Hepatobiliary Surg, 116 Changjiang Rd, Zhuzhou 412000, Peoples R China

[7] Univ Otago, Dept Pathol, Dunedin 9016, New Zealand

来源：

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY | 2024年 / 130卷 / 06期

关键词：

Pancreatic cancer; type; 2; diabetes; relationship; 10; years; drugs; SIGNALING PATHWAY; SGLT2; INHIBITORS; CLINICAL-USE; P38; MAPK; PROMOTES; CELLS; PROGRESSION; MECHANISMS; OBESITY; RAGE;

D O I：

10.1080/13813455.2023.2252204

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pancreatic cancer (PC) is a prevalent gastrointestinal tumour known for its high degree of malignancy, resulting in a mere 10% five-year survival rate for most patients. Over the past decade, a growing body of research has shed light on the intricate bidirectional association between PC and Type 2 diabetes (T2DM). The collection of PC- and T2DM-related articles is derived from two comprehensive databases, namely WOS (Web of Science Core Collection) and CNKI (China National Knowledge Infrastructure). This article discusses the last 10 years of research trends in PC and T2DM and explores their potential regulatory relationship as well as related medications.

引用

页码：660 / 668

页数：9

共 50 条

[31] Singapore cancer trends in the last decade
Lim, G. H.
Chow, K. Y.
Lee, H. P.
SINGAPORE MEDICAL JOURNAL, 2012, 53 (01) : 3 - 9
[32] Nanogels as target drug delivery systems in cancer therapy: A review of the last decade
Attama, Anthony A.
Nnamani, Petra O.
Onokala, Ozioma B.
Ugwu, Agatha A.
Onugwu, Adaeze L.
FRONTIERS IN PHARMACOLOGY, 2022, 13
[33] Identification of the Genetic Association Between Type-2-Diabetes and Pancreatic Cancer
Liang, Yaling
Chen, Wei
Tang, Yun
Chen, Meijuan
BIOCHEMICAL GENETICS, 2023, 61 (03) : 1143 - 1162
[34] Decoding the role of microRNA dysregulation in the interplay of pancreatic cancer and type 2 diabetes
Victoria Mencucci, Maria
Carlos Abba, Martin
Maiztegui, Barbara
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2024, 583
[35] Identification of the Genetic Association Between Type-2-Diabetes and Pancreatic Cancer
Yaling Liang
Wei Chen
Yun Tang
Meijuan Chen
Biochemical Genetics, 2023, 61 : 1143 - 1162
[36] Association between pancreatic cancer and metformin use in patients with type 2 diabetes
Lai, Shih-Wei
Tsai, Chia-Hsun
Lin, Cheng-Li
Liao, Kuan-Fu
POSTGRADUATE MEDICAL JOURNAL, 2019, 95 (1123) : 291 - 291
[37] Type 2 Diabetes Mellitus and Survival in Pancreatic Cancer: A Retrospective Cohort Study
Hwang, Allen
Narayan, Vivek
Yang, Yu-Xiao
GASTROENTEROLOGY, 2012, 142 (05) : S617 - S617
[38] Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review
Dehghanian, Fariba
Azhir, Zahra
Khalilian, Sheyda
Gruening, Bjoern
JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (03) : 405 - 428
[39] Pancreatic and gut hormone responses to mixed meal test differentiate pancreatic cancer associated diabetes from type 2 diabetes
Bao, J.
Zhang, Y.
Sun, C.
Li, L.
DIABETOLOGIA, 2021, 64 (SUPPL 1) : 195 - 195
[40] At last a roadmap for research in diabetes in pregnancy for the coming decade
Dunne, Fidelma
DIABETIC MEDICINE, 2021, 38 (08)

← 1 2 3 4 5 →